News stories about Symmetry Medical (NYSE:SMA) have trended somewhat positive this week, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Symmetry Medical earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave media coverage about the healthcare company an impact score of 44.6962033504294 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
TRADEMARK VIOLATION NOTICE: “Symmetry Medical (SMA) Receives News Sentiment Score of 0.19” was published by Equities Focus and is owned by of Equities Focus. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://www.equitiesfocus.com/2018/01/06/symmetry-medical-sma-receives-news-sentiment-score-of-0-19.html.
Symmetry Medical Company Profile
Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments).
Receive News & Ratings for Symmetry Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symmetry Medical and related companies with MarketBeat.com's FREE daily email newsletter.